The first study analysed the contribution of febrile neutropenia, by tumour type, to medical costs and mortality. The second one examined the budget impact of sargramostim use in patients with chemotherapy-induced neutropenia.EBSCO_AspReactions Weekly...
Chemo-induced neutropenia: impact under-appreciated.The article discusses research on the cost of hospitalisations for chemotherapy-induced neutropenia (CIN). It references studies presented at the 45th Annual Meeting of the American Society of Clinical Oncology." The contribution of febrile neutropenia,...
First is neutropenia. I worry about the risk of infection, the risk of febrile neutropenia, and the risk of opportunistic infections in our already immunocompromised patients receiving high-dose chemotherapy or chemotherapeutic regimens that are highly myelosuppressive. That’s one aspect, and the ...
of Gram-negative septicaemia complicating neutropenia with an oral quinolone, or of Pneumocystis carinii pneumonia with co-trimoxazole. • Suppression of existing infection before it causes overt disease, e.g. tuberculosis, malaria. • Prevention of acute exacerbations of a chronic infection, e.g...
The FDA has issued a complete response letter to Spectrum Pharmaceuticals regarding the biologics license application for eflapegrastimas a potential option for the management of chemotherapy-induced neutropenia.
et al. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?. Support Care Cancer 28, 3103–3111 (2020). https://doi.org/10.1007/s00520-019-05113-4 Download citation Received23 February 2019 Accepted06 October ...
Furthermore, because the DCF regimen frequently induced neutropenia, good care should be taken about myelotoxicity. However, the frequency of myelotoxicity and febrile neutropenia were consistent with that in other studies (Posner et al, 2007; Vermorken et al, 2007), and these were manageable ...
The severity of neutropenia, thrombocytopenia and anemia was not correlated with the presence of cirrhosis or history of prior liver transplantation. However, the severity of thrombocytopenia and anemia was correlated with presence of splenomegaly (p < 0.05). Conclusions: Cytopenia involving one or ...
Even though it is difficult to differentiate between treatment-related and disease-related deaths because both the disease and the treatment may lead to neutropenia and severe infections, we know that most patients who die do so with active HLH. Therefore, prompt diagnosis by modern genetic and ...
(7.8%) 0 Neutropenia 6 (11.8%) 7 (13.7%) 0 Thrombocytopenia 3 (5.9%) 3 (5.9%) 0 Anemia 20 (39.2%) 3 (5.9%) 0 Increased ALT 2 (3.9%) 0 0 Increased AST 1(2.0%) 0 0 Total bilirubin elevation 3 (5.9%) 0 0 Conjugated bilirubin concentration 2 (3.9%) elevation 0 0 ...